Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EK1768 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Cerebrovascular accident
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021327233
Write-up: Stroke; This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Agency. The Regulatory authority report number is (GB-MHRA-WEBCOVID-202103222059565510) and the Safety Report Unique Identifier is (GB-MHRA-ADR 25002071). A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK1768), via an unspecified route of administration on 13Jan2021 at a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient has not had symptoms associated with COVID-19. Patient has not had a COVID-19 test. Patient is not enrolled in clinical trial. The patient experienced stroke on 15Jan2021 and then died on 03Mar2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Stroke
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166